10x Genomics, Inc. TXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.47M+17.1% | -$16.25M+40.8% | -$27.47M-180% | $34.54M+201% | -$34.36M+29.9% | ||
| $9.96M-1.1% | $10.07M-2.3% | $10.3M+31.8% | $7.82M-2.6% | $8.02M-8.3% | ||
| $22.64M-10.2% | $25.22M-0.2% | $25.26M-8.3% | $27.56M-11.3% | $31.08M-4.5% | ||
| —— | $313.25K0.0% | $313.25K0.0% | $313.25K0.0% | $313.25K— | ||
| -$7.98M— | $0+100% | -$6.63M-156% | -$2.59M+92.7% | -$35.33M— | ||
| -$2.7M+51.6% | -$5.58M+23.4% | -$7.29M-3.7% | -$7.03M+12.8% | -$8.06M— | ||
| $4.78M+188% | -$5.42M-2,664% | -$196K-103% | $6.04M+337% | -$2.55M+81.0% | ||
| -$613K-111% | $5.36M-46.9% | $10.1M+229% | -$7.82M— | $0-100% | ||
| -$1.95M-165% | $2.99M+316% | -$1.38M— | —— | $5.53M+113% | ||
| -$50K-167% | $75K-73.3% | $281K-58.7% | $680K+88.9% | $360K+177% | ||
| -$193K+50.9% | -$393K+9.4% | -$434K-23.6% | -$351K+39.0% | -$575K— | ||
| $77K-94.5% | $1.39M+834% | -$190K+76.4% | -$805K-332% | $347K-88.7% | ||
| $1.95M— | —— | —— | —— | $1.79M— | ||
| -$2.85M-4.9% | -$2.72M-4.5% | -$2.6M-10.6% | -$2.36M+10.5% | -$2.63M+3.3% | ||
| -$18.13M— | —— | —— | $68.48M— | $0— | ||
| $26.12M-35.9% | $40.78M-5.6% | $43.21M+144% | $17.71M-48.4% | $34.35M— | ||
| $1.6M-10.1% | $1.78M+159% | $687K-56.5% | $1.58M-16.6% | $1.89M-30.3% | ||
| $24.71M+0.6% | $24.58M-50.3% | $49.5M+0.3% | $49.36M— | $0-100% | ||
| $25M-0.8% | $25.2M-49.6% | $50M0.0% | $50M— | $0— | ||
| -$1.31M+27.4% | -$1.81M+79.5% | -$8.8M-837% | -$939K+50.4% | -$1.89M+96.3% | ||
| $273K-87.8% | $2.24M+263% | $617K-82.5% | $3.52M+735% | $422K-90.7% | ||
| $8.69M— | —— | —— | —— | $0— | ||
| -$8.42M-475% | $2.24M+263% | $617K-82.5% | $3.52M+735% | $422K-90.7% | ||
| -$73K-270% | $43K— | $0-100% | $360K+216% | $114K+142% | ||
| $16.32M-60.4% | $41.26M+17.9% | $35M+69.5% | $20.65M-37.4% | $32.99M+161% | ||
| -$278K-161% | $456K-26.1% | $617K-27.9% | $856K+85.3% | $462K-40.6% | ||
| $57K+121% | -$272K— | —— | —— | $0— | ||
| -$6.14M— | —— | -$7.05M+2.4% | -$7.22M-267% | $4.33M— | ||
| $77K-94.5% | $1.39M+834% | -$190K+76.4% | -$805K-332% | $347K-88.7% | ||
| -$20.96M-491% | $5.36M-46.9% | $10.1M+157% | $3.93M+133% | -$11.75M-415% | ||
| -$2.85M-4.9% | -$2.72M-4.5% | -$2.6M-10.6% | -$2.36M+10.5% | -$2.63M+3.3% | ||
| -$50K-167% | $75K-73.3% | $281K-58.7% | $680K+88.9% | $360K+177% | ||
| -$282K— | —— | —— | -$125K+94.6% | -$2.31M— | ||
| -$18.13M— | —— | —— | $68.48M— | $0— | ||
| -$1.95M-165% | $2.99M+316% | -$1.38M— | —— | $5.53M+113% | ||
| $0— | —— | $700K— | —— | $114K-81.0% | ||
| $1.95M— | —— | —— | —— | $1.79M— | ||
| —— | $313.25K0.0% | $313.25K0.0% | $313.25K0.0% | $313.25K— | ||
| $25M-0.8% | $25.2M-49.6% | $50M0.0% | $50M— | $0— | ||
| $273K-87.8% | $2.24M+263% | $617K-82.5% | $3.52M+735% | $422K-90.7% | ||
| $118K+47.5% | $80K— | —— | —— | $398K+0.3% | ||
| -$2.85M-4.9% | -$2.72M-4.5% | -$2.6M-10.6% | -$2.36M+10.5% | -$2.63M+3.3% | ||
| $8.7M— | —— | —— | —— | $0— | ||
| -$278K-161% | $456K-26.1% | $617K-27.9% | $856K+85.3% | $462K-40.6% | ||
| $24.52M-37.1% | $39M-8.3% | $42.53M+164% | $16.13M-50.3% | $32.46M+443% | ||
| $24.52M-37.1% | $39M-8.3% | $42.53M+164% | $16.13M-50.3% | $32.46M+443% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.